PHASE 2, SINGLE ARM STUDY OF CG0070 COMBINED WITH PEMBROLIZUMAB IN PATIENTS WITH NONMUSCLE INVASIVE BLADDER CANCER (NMIBC) UNRESPONSIVE TO BACILLUS CALMETTE-GUERIN (BCG)

被引：0
|
作者：
Li, Roger [1 ]
Steinberg, Gary [2 ]
Uchio, Edward [3 ]
Lamm, Donald [4 ]
Paras, Shah [5 ]
Kamat, Ashish [6 ]
Bivalacqua, Trinity [7 ]
Packiam, Vignesh [8 ]
Chisamore, Michael [9 ]
McAdory, John [10 ]
Grandi, Paola [10 ]
Hnat, Nataliya [10 ]
Burke, James [10 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res, Tampa, FL USA
[2] NYU Langone Hlth, New York, NY USA
[3] Univ Calif Irvine, Irvine, CA USA
[4] BCG Oncol, Phoenix, AZ USA
[5] Mayo Clin, Rochester, MN USA
[6] Univ Texas MD Anderson, Houston, TX USA
[7] Univ Penn, Philadelphia, PA 19104 USA
[8] Univ Iowa, Iowa City, IA USA
[9] Merck & Co Inc, Kenilworth, NJ USA
[10] CG Oncol, Irvine, CA USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
D O I：
10.1136/jitc-2022-SITC2022.0666
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
666
引用
收藏
页码：A696 / A696
页数：1
相关论文
共 50 条
  • [1] A phase 3, single-arm study of CG0070 in subjects with nonmuscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG).
    Uchio, Edward M.
    Lamm, Donald L.
    Shore, Neal D.
    Kamat, Ashish M.
    Tyson, Mark
    Tran, Ben
    Anderson, Paul
    Grandi, Paola
    Burke, James M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [2] CORE1: Phase 2, single-arm study of CG0070 combined with pembrolizumab in patients with nonmuscle-invasive bladder cancer (NMIBC) unresponsive to bacillus Calmette-Guerin (BCG).
    Li, Roger
    Steinberg, Gary D.
    Uchio, Edward M.
    Lamm, Donald L.
    Shah, Paras
    Kamat, Ashish M.
    Bivalacqua, Trinity
    Packiam, Vignesh T.
    Chisamore, Michael Jon
    McAdory, John
    Grandi, Paola
    Hnat, Nataliya
    Burke, James
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [3] CORE1: Phase 2, Single Arm Study of CG0070 Combined with Pembrolizumab in Patients with Non Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus Calmette-Guerin (BCG)
    Steinberg, Gary D.
    Li, Roger
    Lamm, Donald
    Uchio, Edward
    Packiam, Vignesh
    Kamat, Ashish
    McAdory, John
    Grandi, Paola
    Kim, Jee-Hyun
    Burke, James
    [J]. MOLECULAR THERAPY, 2021, 29 (04) : 319 - 319
  • [4] CORE1: PHASE 2, SINGLE ARM STUDY OF CG0070 COMBINED WITH PEMBROLIZUMAB IN PATIENTS WITH NON MUSCLE INVASIVE BLADDER CANCER (NMIBC) UNRESPONSIVE TO BACILLUS CALMETTE-GUERIN (BCG)
    Li, Roger
    Steinberg, Gary
    Lamm, Donald
    Uchio, Ed M.
    Shah, Paras
    Kamat, Ashish M.
    Hnat, Nataliya
    Chisamore, Michael J.
    Grandi, Paola
    Burke, James
    [J]. JOURNAL OF UROLOGY, 2022, 207 (05): : E927 - E927
  • [5] CORE1: PHASE 2, SINGLE ARM STUDY OF CG0070 COMBINED WITH PEMBROLIZUMAB IN PATIENTS WITH NON MUSCLE INVASIVE BLADDER CANCER (NMIBC) UNRESPONSIVE TO BACILLUS CALMETTE-GUERIN (BCG)
    Li, Roger
    Steinberg, Gary
    Lamm, Donald
    Uchio, Ed
    Packiam, Vignesh
    Kamat, Ashish
    Chisamore, Michael
    McAdory, John
    Grandi, Paola
    Kim, Jee-Hyun
    Burke, James
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A1005 - A1005
  • [6] CORE1: Phase 2, single arm study of CG0070 combined with pembrolizumab in patients with non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG).
    Rixe, Olivier
    Castonguay, Vincent
    Conter, Henry
    Chalas, Eva
    Desai, Pratibha
    Squillante, Christian
    MacDonald, Lisa A.
    Conlon, Rebekah
    Bramhecha, Yogesh
    Hirsch, Heather
    Graff, Jeremy R.
    Fiset, Stephan
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [7] CG0070 for the treatment of non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG)
    Uchio, Edward M.
    Li, Roger
    Steinberg, Gary
    Lamm, Donald
    Kamat, Ashish
    Packiam, Vignesh
    Anderson, Paul
    Ku, Ja Hyeon
    Chisamore, Michael
    McAdory, John
    Hnat, Nataliya
    Kim, Jee-Hyun
    Grandi, Paola
    Burke, James
    [J]. CANCER SCIENCE, 2023, 114 : 1587 - 1587
  • [8] CG0070 for the treatment of non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG)
    Li, R.
    Uchio, E.
    Steinberg, G. D.
    Shore, N.
    Anderson, P. D.
    Ben, T.
    Kamat, A.
    Keel, M.
    Packiam, V.
    McAdory, J.
    Kim, J. H.
    Chisamore, M.
    Grandi, P.
    Burke, J.
    [J]. HUMAN GENE THERAPY, 2021, 32 (19-20) : A130 - A130
  • [9] CORE1: PHASE 2 SINGLE ARM STUDY OF CG0070 COMBINED WITH PEMBROLIZUMAB IN PATIENTS WITH NON MUSCLE INVASIVE BLADDER CANCER UNRESPONSIVE TO BACILLUS CALMETTE-GUERIN (BCG)
    Li, Roger
    Steinberg, Gary
    Uchio, Edward M.
    Lamm, Donald
    Shah, Paras
    Kamat, Ashish M.
    Bivalacqua, Trinity J.
    Packiam, Vignesh
    Chisamore, Michael J.
    Mcadory, John
    Grandi, Paola
    Hnat, Nataliya
    Burke, James
    [J]. JOURNAL OF UROLOGY, 2023, 209 : E408 - E409
  • [10] A phase 3, single-arm study of CG0070 in subjects with non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG).
    Uchio, Ed
    Lamm, Donald
    Shore, Neil
    Bivalacqua, Trinity
    Kamat, Ashish
    Tyson, Mark
    Anderson, Paul
    Grandi, Paola
    Burke, James
    [J]. CANCER RESEARCH, 2022, 82 (12)
12345